Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Japan.
Department of Radiology, Saitama Cardiovascular and Respiratory Center, Japan.
Intern Med. 2024 Aug 1;63(15):2167-2171. doi: 10.2169/internalmedicine.2562-23. Epub 2023 Dec 18.
An 80-year-old woman who developed allergic bronchopulmonary aspergillosis (ABPA) was admitted to our institution in 2023 for an enlarged pulmonary mass lesion. She had developed ABPA in 2017, and corticosteroid therapy had improved the mucoid impaction of the bronchi. Because part of the lesion remained, increased doses of corticosteroid, antifungals, and biologics were administered, but the pulmonary lesion enlarged in 2022. Bronchoscopy showed necrotic tissue in the bronchial lumen, and bronchial washing fluid showed neutrophilic inflammation and fungal hyphae. We subsequently diagnosed her as having chronic pulmonary aspergillosis overlapping ABPA, and voriconazole was started that resulted in shrinkage of the nodules.
一位 80 岁的女性于 2023 年因肺部肿块就诊于我院,她曾于 2017 年患变应性支气管肺曲霉病(ABPA),皮质类固醇治疗改善了支气管黏液嵌塞。由于部分病变仍存在,给予了更高剂量的皮质类固醇、抗真菌药物和生物制剂,但 2022 年肺部病变仍在增大。支气管镜检查显示支气管腔内有坏死组织,支气管灌洗液显示中性粒细胞炎症和真菌菌丝。随后我们诊断为慢性肺部曲霉病重叠 ABPA,开始使用伏立康唑治疗,结果结节缩小。